Home' Australian Pharmacist : Australian Pharmacist September 2012 Contents 680 Australian Pharmacist September 2012 I ©Pharmaceutical Society of Australia Ltd.
On Sunday the focus changes with
headline speaker Dr Caroline Harvey, from
Family Planning Queensland, looking at
contraception issues, including emergency
contraception. The guidelines for
emergency contraception have changed
and this session is a great opportunity for
pharmacists to bring themselves up to
speed on the latest developments.
In addition, there will be presentations on
managing drugs in breastfeeding and the
often confusing area of infant formulas.
PSA members can attend the weekend and
earn up to 20 CPD credits. For more details
The need for greater collaboration between
healthcare professionals and to put the
focus on patients and their health outcomes
were the central themes to emerge from
a special session of the World Health Care
Networks Conference held in Cairns at the
end of July.
with General Practice,
was facilitated by
PSA CEO Liesel Wett,
and included a panel
of prominent GPs
and pharmacists from Australia and New
The interactive session highlighted
the collaborative models of care being
delivered to consumers by GP and
pharmacist teams in Australia and
The relaxed session format gave
participants the opportunity to discuss the
challenges and successes of working daily
with health consumers, and to highlight
working solutions that build on the
strengths of both professions.
Ms Wett said there was much debate during
the session which brought out a consensus
that collaboration between the professions
was essential to future healthcare models.
'The panel also highlighted the
need to ensure the patient and their
health outcomes are the focus of that
collaboration. It was refreshing to also hear
of some of the very smart and innovative
work being undertaken in both Australia
and New Zealand in some key areas such as
'I was especially interested to hear the
panel's examination of the development of
integrated and collaborative relationships
which are based on trust.
'One thing that emerged very clearly is the
realisation that pharmacists and GPs now
understand they are not competing; they are
complementary and have a shared need to
get the best for the patient.'
Ms Wett said the challenge was for the health
professions to get it right when developing
and implementing the drivers for shared care.
'The session built on themes that had
emerged during the conference particularly
around the need for GPs and pharmacists
to both see value from the relationship.
Communication is a key at the local level and
understanding one another's roles is critical
to developing a more collaborative model of
practice,' she said.
The London Olympics provides a timely
reminder that pharmacists need to be totally
aware of what they are dispensing and the
patient circumstances which impact on
medicine use. Elite athletes subject to doping
control testing can face serious consequences
if banned substances are inadvertently taken.
In the six months leading up to the London
Olympics, more than 70,000 tests were
carried out worldwide and more than 100
athletes sanctioned. Samples will be stored
for eight years after the Games which
means that, long after the closing ceremony,
re-testing can occur.
Some athletes may be well aware of the
list of substances that are banned for their
sport but many factors can contribute to an
athlete requiring timely advice about banned
substances from a pharmacist.
PSA President Grant Kardachi said the
Olympics reminds us of the need for
pharmacists to have the resources available to
check on the medicines they are dispensing
and, in the case of elite athletes, to be able to
check if they are banned substances.
'PSA's de nitive reference work APF22
provides information to assist pharmacists
in their dispensing and other aspects of their
pharmacy practice,' Mr Kardachi said.
'The section Drugs in Sport is especially
helpful in the case of elite athletes as it details
the processes that a pharmacist should go
through when dispensing any medicines for
athletes subject to doping control testing.
Sunshine with Ian Frazer
An examination of the latest advances in
skin cancer, in particular melanoma, will be
a highlight of the PSA Sunshine Weekend in
Professor Ian Frazer,
famous for his work
on the Gardasil
vaccine, will open the
being held on the
Gold Coast from September 15--16, with,
an address on the topic of Skin Cancer
from Bench to Bedside during which he
will present on some exciting research
advances that have been made recently
and the potential for new treatments on the
Australians have the highest rates of skin
cancer in the world, with up to 50% of
Australians su ering some form of skin
cancer during their life.
Professor Frazer is the Chief Executive
O cer and Director of Research of the
Translational Research Institute (TRI) in
Brisbane, Australia where he is charged
with leading the $354 million TRI to
achieve its mission of being Australia's rst
institute -- and one of only a few in the
world -- to research, trial and manufacture
breakthrough drugs in the one location.
He was awarded the 2005 CSIRO Eureka
Prize for Leadership in Science and was
selected as Queenslander of the Year and
Australian of the Year in 2006. He was also
awarded the 2008 Prime Minister's Prize for
Science, the 2008 Balsan Prize for Preventive
Medicine, the 2009 Honda Prize and was
recently elected as a Fellow of the esteemed
Royal Society of London.
In 2012, Professor Frazer was appointed a
Companion of the Order of Australia (AC) in
the Queen's Birthday honours list.
After Professor Frazer's address, the
Sunshine Weekend will continue with
its dermatology theme and look at how
to better manage psoriasis and other
troublesome skin conditions in the
On Saturday afternoon, the conference
will get down to the practicalities of
implementing the new 5CPA programs of
MedsCheck and Diabetes MedsCheck.
Links Archive Australian Pharmacist October 2012 Australian Pharmacist August 2012 Navigation Previous Page Next Page